Save the Date!
Next Patient Workshop
Sunday, Feb. 19, 2012 at the
Hilton Dallas-Fort Worth, Texas Lakes Executive Conference Center.
| | | |
Therapy Tip
We've found no scientific rationale to evaluate recovery of the immune system on the basis of stages. Based on our clinical observation, we believe "stage 5" is a faulty concept without validity. Read more...
| | |
Our Library |
Access to our extensive, easy-to-read Library of Information (see this sample page)and Physicians' Reference Library is available to anyone, without enrollment in our counseling program.  If you're interested in using this resource, please send your request to our email, along with your doctor's name and fax number (in the US and Canada) or his/her email address so we can notify your doctor that you have access to this information. A list of the articles in our library is available at this link. Physicians may use CIR libraries even if they don't have a patient enrolled in our counseling program. Interested medical professionals should contact CIR and ask to register.
|
CIR Organization
CIR is an IRS-recognized
501(c)3 non-profit, charitable organization. Donations allow us to fulfill our mission and every gift is appreciated. Donate Online Here | |
Survey
Volunteers who have a diagnosis of autoimmune or inflammatory disease or are chronically ill but who are not being treated with Inflammation Therapy, the Marshall Protocol or the Stillpoint Protocol are needed to be in the control group of our clinical study.
If you meet these criteria and would like to take part in this project (which will only take a few minutes each week), please contact us
via email.
| | | |
Contact Information | CIR email address
Phone CIR toll-free in the US and Canada
1-888-846-2474 Are you a Skype User? Look for Chronic.Illness.Recovery
|
|
|
Greetings!
Spring is a time of new growth and here at CIR it seems we're always developing something new. We recently created a lovely web page, including photos, about our recent successful Patient Workshop and Physicians' Seminar. You can also read the latest information on finding a supportive medical practitioner, the differences between IT and the MP, Benicar dosing, the importance of therapy antibiotics, treatment effectiveness and clinical studies.
These articles and more are listed on our "What's New" web page.
We hope you'll help us promote our efforts to inform medical practitioners about chronic inflammation and managing Inflammation Therapy. Our resources are available to all interested clinicians without cost. If your doctor is not yet registered for full access to our website/forum please ask him/her to contact us at
our email address
Best regards,
 
|
About Inflammation Therapy |
Inflammation Therapy doesn't dictate that taking vitamin D3 or D2 is always immunosuppressive, based upon computer modeling simulations. At CIR, we are interested in following and docum enting results in patients. We see that lowering 25-D to a reasonable level can help lower higher 1,25-D levels that reflect too much systemic inflammation.
Lowering secosteroid D intake and sun exposure on skin is a strategy for those with a dysfunctional D-metabolism to have some symptomatic improvement. The primary reason to avoid D2 and D3 ingestion or sun exposure is because these can make people very ill, and this is certainly the case for most patients, at least at the beginning of IT treatment.
We do not advocate that people maintain levels of 25-D too low to measure, but only to keep it low enough to control elevations in 1,25-D. This helps avoid the danger of patients developing osteomalacia, and recognizes that both 25-D and 1,25-D have a normal role to play in mammalian physiology that cannot be totally replaced with olmesartan or any other secosteroid D analog. As people recover, they are often eventually able to thrive while eating food with D2 and D3, and do well in the sunlight, even permitting sun exposure on the skin in reasonable, controlled amounts. Although we feel certain that olmesartan must be a vitamin 1,25-D analog (or significantly affect the VDR), based upon patient responses, we fully understand the need for this to be verified in full by scientific research.
We do clearly see that olmesartan permits very low doses of selected antibiotics to be dramatically potentiated by a factor of many magnifications, which can in no way be attained with increasing doses of the select antibiotics. We fully welcome the day when controlled and fully independent clinical trials can be done with Inflammation Therapy. We have no financial interest in any patent applications related to Inflammation Therapy or the manufacture of any of the medications IT utilizes.
Supplements are part of many alternative treatments for chronic illness, and many chronically ill patients are accustomed to taking a variety of supplements. Some have an obvious palliative effect; others are needed to replace essential substances, while others are merely touted to improve health.
|
About Chronic Illness Recovery |
Chronic Illness Recovery believes it's important to make up-to-date instructions about the management of Inflammation Therapy available to all interested clinicians. To that end, we have recently revised our Physicians' Guide to Inflammation Therapy. In keeping with our philosophy of tailoring treatment based on individual response to therapy, we've added many important features such as diagnosing chronic inflammation, monitoring lab values, assessing the correct dose of Benicar and maintaining optimal levels of vitamin D metabolites during the recovery process.
This document is a guide for basic treatment and includes all the details regarding therapy medications, photosensitivity, palliative medications and managing Herxheimer reactions. If it's followed correctly, most patients will do well. However, some may need to use other strategies or modalities and Chronic Illness Recovery is available if additional guidance is needed.
This invaluable resource is available to patients whose doctor authorizes their enrollment in the CIR counseling program. Other patients may access the Guide in our Library of Information. See CIR Library Access in the sidebar of this newsletter.
|
New Scientific Articles |
 |
Photo Content: CDC/ Matthew J. Arduino, DRPH
Photo Credit: Janice Haney Carr
|
Antibiotics, Acne, and Staphylococcus aureus Colonization
This study concludes: Unlike current dogma about the long-term use of antimicrobial agents, the prolonged use of tetracycline antibiotics commonly used to treat acne lowered the prevalence of colonization by S. aureus and did not increase resistance to the tetracycline antibiotics.
From the bench to emerging new clinical concepts - Our present understanding of the importance of the vitamin D endocrine system (VDES) for skin cancer
One of the conclusions of this paper states that "...significant associations with VDR polymorphisms and/or 25-hydroxyvitamin D serum levels have been reported in malignant melanoma as well as in non melanoma skin cancer."
|
Quotable Quotes |
"I so appreciate the work of the CIR team; their ongoing support of all of us via CIR website, patient posts, and now workshops, where it was so apparent their level of knowledge, professionalism,

and compassion." ~ Noel
"Your help to me has been extraordinary! Thank you so much. I asked my doctor if the service CIR was providing was helpful. Her response was an immediate resounding, "Thank you. It's so worthwhile.'" Sue from St. Louis
|
|
|
|